Puma Biotechnology Inc.

NASDAQ: PBYI · Real-Time Price · USD
5.67
0.35 (6.58%)
At close: Aug 15, 2025, 12:51 PM

Puma Biotechnology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
230.47M 235.64M 228M 253.2M
Cost of Revenue
64.4M 62.68M 55.1M 63.7M
Gross Profit
166.06M 172.96M 172.9M 189.5M
Operating Income
30.97M 32.64M 23.7M 1.29M
Interest Income
4.72M 2.6M 813K 100K
Pretax Income
24.1M 22.67M 457K -28.8M
Net Income
30.28M 21.59M 2K -29.1M
Selling & General & Admin
80.16M 89.31M 90M 116.3M
Research & Development
54.94M 50.38M 52.2M 71.9M
Other Expenses
n/a 625K 7.02M n/a
Operating Expenses
135.1M 140.31M 149.22M 188.2M
Interest Expense
12.45M 13.33M 11.59M 12.8M
Selling & Marketing Expenses
-519K 881K 22K 6K
Cost & Expenses
199.5M 203M 204.31M 251.9M
Income Tax Expense
-6.18M 1.08M 500K 324K
Shares Outstanding (Basic)
48.65M 47.13M 44.67M 40.64M
Shares Outstanding (Diluted)
49.1M 47.55M 44.93M 40.64M
EPS (Basic)
0.62 0.46 0.02 -0.72
EPS (Diluted)
0.62 0.45 0.02 -0.72
EBITDA
48.08M 47.52M 20.97M -5.4M
EBIT
36.55M 36M 12.05M -15.99M
Depreciation & Amortization
11.52M 11.52M 8.92M 10.6M